Jon spent nine years in clinical practice before joining USVP in 1995 as a Ewing Marion Kauffman Fellow in venture capital. He became a general partner in 1997. Before USVP, Jon was on the faculty and clinical staff at The New York Hospital-Cornell Medical Center in New York City. There he was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit. He is board certified in neurology.
Jon is currently on the boards of USVP portfolio companies of Cleave Biosciences, eFFECTOR Therapeutics, HealthJoy, Inari Medical, Nuvaira, Okami Medical, Omada Health, Ribon Therapeutics, Route92 and Silverback Therapeutics. Jon is a former board member for the National Venture Capital Association (NVCA).
Sign up to view 0 direct reports
Get started